Biomedical Research

Objective: The aim of this article was to comprehensively examine the current and project burden of hypertensive cerebral hemorrhage in southwest region of China. Methods: Summary and analysis of the data of the patients from the Sichuan Province Forestry Centre Hospital, the Second Affiliated Hospital of Kunming Medical University, the West China Hospital of Sichuan University, the Yunnan University of Traditional Chinese Medicine, 2010-2017. Results: The medical cost of patients with hypertensive intracerebral hemorrhage was estimated at RMB 12196.00 (USD 1896.73) per person per year. The total costs of intracerebral hemorrhage were higher in surgery group (RMB 36632.50 or USD 5697.12) than non-surgery group (RMB 6333.00 or USD 984.91). The direct medical costs of surgery group were RMB 32534.00 (USD 5059.72), in contrast with the costs of non-surgery treatments, which were RMB 3781.75 (USD 588.14). Conclusion: In this paper, all 1640 cases of hypertensive intracerebral hemorrhage research data and follow-up data, we learned that the economic burden of hypertensive cerebral hemorrhage is heavy for the Chinese people and the nation.

Author(s): Mu He, Yanhua Zhang, Chao Huang, Han Li, Hao Li, Chao You, Xiaoli Min
Abstract | Full-Text | PDF

Share this